In one aspect, the invention provides novel compounds useful for treating bacterial infections, such as but not limited to Gram-negative bacterial infections. In another aspect, the invention provides novel compounds useful for activating γδ T cell response during bacterial infections, such as but not limited to infections with Helicobacter pylori. In certain embodiments, the compounds of the invention are IspH inhibitors.
本发明提供了用于治疗细菌感染的新型化合物,例如但不限于革兰氏阴性细菌感染。在另一个方面,本发明提供了用于在细菌感染期间激活γδT细胞反应的新型化合物,例如但不限于幽门螺杆菌感染。在某些实施例中,本发明的化合物是IspH
抑制剂。